Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Status Not FDA-approved as of June 2026
Cell migration TB-500 has been studied for actin binding effects that enable repair cells (including stem cells) to move toward and into tissue requiring repair
If appropriate, the provider may prescribe weight-loss medication, build a dosing plan, and monitor side effects and progress
Both Ozempic and Rybelsus are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication "off-label" for weight loss, as is permissible by the FDA
Journal of Cancer Therapy
Stacking for Synergy Stacking for Synergy BPC-157 + TB-500: Combining BPC-157s angiogenic and nitric oxidemodulating effects with TB-500s cell-migration boost may accelerate musculoskeletal repair
US$ 23.89
US$ 28.94
US$ 25.13
US$ 21.46
US$ 25.88
